| Drug Name: | 4-AcO-DALT |
| Cas Number: | 1445751-71-2 |
| Pubchem: | 119025857 |
| Chemspiderid: | 32078886 |
| Unii: | 2Z8WS8Z4T1 |
| Synonyms: | 4-Acetyloxy-N,N-diallyltryptamine; 1H-Indol-4-ol, 3-(2-(di-2-propen-1-ylamino)ethyl)-, 4-acetate; 3-(2-(Di(prop-2-en-1-yl)amino)ethyl)-1H-indol-4-yl acetate; Dalcetin |
| Iupac Name: | [3-[2-[bis(prop-2-enyl)amino]ethyl]-1H-indol-4-yl] acetate |
| C: | 18 |
| H: | 22 |
| N: | 2 |
| O: | 2 |
| Smiles: | CC(=O)Oc1cccc2c1c(c[nH]2)CCN(CC=C)CC=C |
| Stdinchi: | 1S/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3 |
| Stdinchikey: | WRHFDIBXZYYCHO-UHFFFAOYSA-N |
4-Acetyloxy-N,N-diallyltryptamine (or 4-AcO-DALT) is a tryptamine derivative. It has been sold as a designer drug, but little other information is available. It was first officially identified in seized drug samples in 2012.[1]